Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02297 RAINMED-B > Detailed Quotes

02297 RAINMED-B

Watchlist
1.250
-0.050-3.85%
Closed  02/03 16:08 CCT
High
1.340
Open
1.290
Turnover
194.45K
Low
1.250
Pre Close
1.300
Volume
153.00K
Market Cap
1.46B
P/E(TTM)
Loss
52wk High
6.100
Shares
1.17B
P/E(Static)
Loss
52wk Low
1.250
Float Cap
1.46B
Bid/Ask %
-80.56%
Historical High
6.100
Shs Float
1.17B
Volume Ratio
8.69
Historical Low
1.250
Dividend TTM
--
Div Yield TTM
--
P/B
-0.61
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
6.92%
Avg Price
1.270
Lot Size
1000
Float Cap
1.46B
Bid/Ask %
-80.56%
Historical High
6.100
Shs Float
1.17B
Volume Ratio
8.69
Historical Low
1.250
Dividend TTM
--
P/B
-0.61
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
6.92%
Avg Price
1.270
Lot Size
1000
Price Forecast

News

Comment

No More
Company Overview More
Founded in 2014, Runmide Medical Group strives to become the world's leading intervascular surgery robot company. Currently, it focuses on the design, development and commercialization of coronary angiography blood flow reserve score (CAFFR) systems and coronary angiography microvascular resistance index (caMR) systems. Runmide Healthcare innovates and is proactive, gradually weaving into a global R&D, production, sales and service network. RunMed Healthcare has actively cooperated with top medical centers and experts at home and abroad to establish a complete patent system, and many research results have continued to be published in authoritative magazines such as “Immunity Research” and “JACC: Anomalous Disorders”. Furthermore, the company has signed strategic cooperation agreements with many top medical device distribution service platforms in China, formulated strict quality inspection systems and perfect supply processes, and successfully passed medical device quality management system certification. In the future, Runmide Medical will adhere to the purpose of “shaping precision medicine and serving the health of all”, rely on technological accumulation in control algorithms, image navigation, image intelligence, evidence-based medicine, etc., launch interventional surgical robots, and gradually build unmanned operating rooms to enhance the clinical value of products and create a new situation of precision medicine in the field of intervention.
CEO: Yunfei Huo
Market: Hong Kong motherboard
Listing Date: 07/08/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist